Screener
Jasper Therapeutics, Inc. JSPR Q4 2025 Annual earnings
Reported March 30, 2026 · Before market open
EPS-$0.32Beat by $0.47
EPS estimate-$0.79
Next report
Nov 9, 2026 (In 1 week)Revenue estimate$6.0M
EPS estimate-$0.06
Versus estimates
Diluted EPS
FAQ
- When did Jasper Therapeutics, Inc. report Q4 2025 earnings?
- Jasper Therapeutics, Inc. (JSPR) reported Q4 2025 earnings on March 30, 2026 before market open.
- What were Jasper Therapeutics, Inc.'s Q4 2025 revenue and EPS?
- Jasper Therapeutics, Inc. reported eps of $-0.32 for Q4 2025.
- Did Jasper Therapeutics, Inc. beat estimates in Q4 2025?
- EPS beat the consensus estimate of $-0.79 by $0.47.
- How did Jasper Therapeutics, Inc.'s Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 80.2% from $-1.62.
- Where can I find Jasper Therapeutics, Inc.'s Q4 2025 SEC filings?
- You can read the 8-K earnings release (0001213900-26-036448) and the 10-K periodic report (0001213900-26-036426) directly on SEC EDGAR. The filing index links above go to sec.gov.
